One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly ...

The company has so far only launched Wegovy in the U.S., Britain, Germany, Norway, and its home market Denmark. Wegovy is the first-to-market in a new class of highly effective weight-loss drugs.

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

It came after Denmark said on Monday it plans to spend $2.05 billion to boost its military presence in the Arctic. While the Scandinavian country is responsible for Greenland's security and ...

Denmark said on Monday it would spend 14.6 billion Danish kroner ($2.05 billion) boosting its military capabilities in the Arctic – a decision that comes amid continuing furor following US Presi ...

By Kenneth P. Vogel Reporting from Washington The government of Denmark has not historically been a big spender on Washington lobbying. But days before President Trump took office for a second ...

President Trump told Denmark’s leader he wanted to take over Greenland, European officials say. Denmark has asked its E.U. allies not to inflame the situation until Mr. Trump’s intentions are ...

Denmark has said it will spend 14.6 billion kroner (£1.6bn; $2.05bn) to boost security in the Arctic region, in partnership with its autonomous territories Greenland and the Faroe Islands.

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...